Literature DB >> 15207130

[Visceral leishmaniasis related to infliximab administration].

Verónica Romaní-Costa, Carlos Sánchez, Francesca Moyá, Cristina Estany.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15207130     DOI： 10.1016/s0213-005x(04)73098-0

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN： 0213-005X            Impact factor:   1.731


× No keyword cloud information.
  4 in total

1.  Case Report: Diffuse Cutaneous Leishmaniasis by Leishmania infantum in a Patient Undergoing Immunosuppressive Therapy: Risk Status in an Endemic Mediterranean Area.

Authors:  M Magdalena Alcover; Vicenç Rocamora; M Carmen Guillén; Diana Berenguer; Marta Cuadrado; Cristina Riera; Roser Fisa
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

2.  Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.

Authors:  Pau Bosch-Nicolau; Maria Ubals; Fernando Salvador; Adrián Sánchez-Montalvá; Gloria Aparicio; Alba Erra; Pablo Martinez de Salazar; Elena Sulleiro; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-08-30

Review 3.  Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.

Authors:  John M Curtin; Naomi E Aronson
Journal:  Microorganisms       Date:  2021-03-11

Review 4.  Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.

Authors:  Ioannis D Xynos; Maria G Tektonidou; Dimitrios Pikazis; Nikolaos V Sipsas
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.